Pharmaceuticals manufacturer and distributor
Pfizer have been operating in Australia since 1956. They operate three manufacturing plants in Australia.
|Pfizer Australia Pty Ltd||AUS||website|
| Pfizer Inc
owns 100% of Pfizer Australia Pty Ltd
|Pfizer Australia Pty Ltd|
|No assessment data currently available for Pfizer Australia Pty Ltd|
In 2020, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security Score of A-.
Source: CDP (2020)
In 2020, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of B.
Source: CDP (2020)
This company is listed as having best practice on a report card on lesbian, gay, bisexual and transgender equality in corporate America.
Source: Human Rights Campaign (2021)
As You Sow's 2019 report, Mining the Disclosures, is a deep analysis of 215 companies' human rights performance in relation to sourcing conflict minerals from the Democratic Republic of the Congo (DRC). This company's score was 1.7% (Weak).
Source: As You Sow (2019)
This company appears on Global Exchange's list of "Most Wanted" Corporate Human Rights Violators (Alums) for killer price-gouging.
Source: Global Exchange (2017)
In 2015 Pfizer experimented on thousands of animals in its own laboratories and many more in experiments in contract testing laboratories.
Source: PETA (2015)
This company appears on PETA's (People for the Ethical Treatment of Animals, USA) 'Companies That Do Test On Animals' list, signifying that they manufacture products that are tested on animals at some stage of development.
Source: PETA (2020)
This company received a score of 38.3/100 in the Newsweek Green Ranking 2017, which ranks the world's largest publicly traded companies on eight indicators covering energy, greenhouse gases, water, waste, fines and penalties, linking executive pay to sustainability targets, board-level committee oversight of environmental issues and third-party audits. Ranking methodology by Corporate Knights and HIP Investor.
Source: Newsweek (2017)
This company received a score of 11.2/100 (retrieved 10-Oct-2020) in the Corporate Information Transparency Index (CITI), a system for evaluating supply chain practices in China, particularly in regards to environmental management and water pollution. Scores are calculated using government compliance data, online monitoring data, and third-party environmental audits, as well as trends in the environmental performance of factories in the company's supply chains.
Source: IPE (2020)
In 2019 several pharmaceutical companies finally settled a 2005 lawsuit which claimed the companies fudged wholesale drug prices to increase Medicaid reimbursements. In all, the state of Illinois received a combined $648 million over the course of that litigation. This company paid US$60 million in the 2019 settlement.
Source: news article (2019)
A 2018 report by Oxfam shows that four pharmaceutical corporations, including this one, systematically hide their profits in overseas tax havens. This activity could deprive developing countries of more than $100 million every year. These corporations deploy massive influencing operations to rig the rules in their favor and give their damaging behavior a veneer of legitimacy. Tax dodging, high prices, and influence peddling by drug companies exacerbate the yawning gap between rich and poor, between men and women, and between advanced economies and developing ones.
Source: Oxfam (2018)
In 2016 this company agreed to pay US$486 million to settle litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. The settlement ended more than 11 years of litigation.
Source: New article (2016)
This company is on OpenSecrets.org's list of "Top Donors", a list of the 100 biggest givers in US federal-level politics since 1990. Companies on this list lobby and spend big, with large sums sent to candidates, parties and leadership PACs. This company comes in at number 93 on the list, with contributions totalling $30,954,692 between 1990 and 2020.
Source: Open Secrets (2020)
This company received an S&P Global ESG Score of 31/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 7 Feb 2021). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2021)
This company is on OpenSecrets.org's list of "Top Spenders on Lobbying", a list of the 20 organizations that have spent the most trying to influence US government policy. This company comes in at number 15 on the list, having spent $12,630,000 on lobbying in 2020.
Source: Open Secrets (2021)
In 2021 this company agreed to pay US$345 million to settle a class action lawsuit that claiming Pfizer and Mylan plotted to maintain EpiPen's monopoly by issuing large rebates to insurers and Medicaid plans that refused to cover competing medications. The class action was filed after the price of EpiPens rose from $100 to $600 in under 10 years.
Source: Top Class Actions (2021)
A 2015 report by Sum Of Us reveals that the largest pharmaceutical corporations are complicit in fuelling one of the most serious public health crises facing society today. Pharmaceutical companies, including this one, are sourcing active pharmaceutical ingredients (APIs) from companies in China which are responsible for massive environmental pollution from its antibiotic factories. Pfizer is among the well-known brand names which has sourced antibiotics for human and animal use from NCPC, a company that stands accused of discharging pharmaceutical effluent into the environment and numerous other serious manufacturing deficiencies.
Source: Changing Markets (2015)
In 1992, Greenpeace listed a Pfizer plant as one of the ten worst polluters in the South East of England. The plant had breached its discharge consent four times since the beginning of 1991 and also discharged ten chemicals for which it did not have a permit, including organochlorines. Pfizer was the target of a Greenpeace campaign in 1988 for dumping industrial waste in Eire, and a US group listed Pfizer as one of the top fifteen corporate contributors to global pollution, based on 1987 figures. (Noted here as 'additional information only' due to age of report).'
Source: McSpotlight (1992)
In 2009 Pfizer copped the largest US criminal fine ever (US$2.3 billion), in the settlement of allegations that it had illegally marketed its painkiller Bextra and other drugs. Pfizer also faces lawsuits over other drugs, namely Reglan, Zoloft and Effexor. [Listed under Information due to age of court finding]
Source: New article (2009)
In 2019 the median pay for a worker at this company was US$98,972. The CEO was paid 181 times this amount. Exorbitant CEO pay is a major contributor to rising inequality. CEOs are getting more because of their power to set pay, not because they are increasing productivity or possess specific, high-demand skills. The economy would suffer no harm if CEOs were paid less (or taxed more). In contrast, the CEO-to-typical-worker compensation ratio was 20-to-1 in 1965 and 58-to-1 in 1989.
Source: AFL-CIO (2020)
As You Sow's 2019 report, 'The 100 Most Overpaid CEOs', reveals the 100 most overpaid CEOs from USA's 500 largest public companies (as determined by the S&P 500 list). This company's CEO, Ian Read came in at number 44 on the list, having been paid US$27,913,775 in 2018. According to the report, "Most CEOs have come to be grossly overpaid, and that overpayment is harmful to the companies, the shareholders, the customers, the other employees, the economy, and society as a whole."
Source: As You Sow (2019)
Named one of Multinational Monitor's '10 Worst Corporations' in 2006. [Listed under Information due to age of report]
Source: Multinational Monitor (2006)
In August 2012 Pfizer agreed to pay a US$60 million court settlement after allegedly bribing foreign officials in Europe and Asia to speed up drug approvals, and give preference to Pfizer drugs in their countries' public health programs, which in turn generated billions of dollars for the world's largest drug company. [Listed under Information due to age of court finding]
Source: news article (2012)
This company is listed on the Federal Contractor Misconduct Database as having 11 instances of misconduct since 1995 amounting to US$3.4 billion in penalties. Instances include illegal marketing, false claims, and whistleblower retaliation.
Source: Project on Government Oversight (POGO) (2014)
As listed on the We Mean Business website, this company has committed to the following climate action initiatives: adopt a science-based emissions reduction target.
Source: We Mean Business (2021)
Compassion in World Farming is a UK-based organisation which works with the European food industry to encourage and reward commitment, transparency, performance and innovation in the field of animal welfare. This company's UK subsidiary won their Good Egg Award in 2012.
Source: Compassion in World Farming (2012)
The United Nations Global Compact asks companies to embrace, support and enact, within their sphere of influence, a set of 10 values in the areas of human rights, labour standards, the environment, and anti-corruption. However it's non-binding nature has been widely criticised, and many signatory corporations continue to violate the Compact's values.
Source: UN Global Compact (2020)
This company is a member of the AMR Industry Alliance, a coalition of biotech, diagnostics, generics and research-based pharmaceutical companies set up to provide sustainable solutions to curb antimicrobial resistance (AMR). AMR is an increasingly significant threat to global public health which puts at risk the effective prevention and treatment of a wide range of infections.
Source: AMR Industry Alliance (2021)
This company received the eleventh highest score in the Access to Medicine Index 2018, a ranking of the world's 20 largest pharmaceutical companies on their efforts to increase access to medicine in developing countries.
Source: Access to Medicine Index (2018)
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
Source: Modern Slavery Registry (2017)
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
Source: Open Secrets (2020)
JUST Capital polls Americans every year to identify the issues that matter most in defining just business behaviour. For their 2021 rankings the public identified 19 issues, which are organised under the headings Workers, Communities, Customers, Shareholders and Environment. JUST Capital then define metrics that map to those issues and track and analyse the largest, publicly traded U.S. companies. This analysis powers their rankings, in which this company ranked 281th of 928 companies, and 13th of 51 Pharmaceuticals & Biotech companies.
Source: JUST Capital (2020)
The Corporate Research Project's Corporate Rap Sheets are dossiers summarising the most significant crimes, violations and other questionable activities of the world's largest and most controversial companies. Follow link to see this company's Corporate Rap Sheet.
Source: Corporate Research Project (2018)
|Revenue||432 million AUD (2018)|
|Address||Level 15-18, 151 Clarence St, Sydney, NSW, 2000, Australia|
|Phone||02 9850 3333|